Prawo i regulacje · 30/03/2010

DEA Proposes Exemption of River Edge Pharmaceutical's Servira for Prescription Use

The US Drug Enforcement Administration (DEA) has proposed adding Servira, a prescription medication developed by River Edge Pharmaceutical, to the list of Exempted Prescription Products, citing a lack of potential for abuse.